SCHEMBL10122280

SCHEMBL10122280

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CN(C)C(=O)SC2CCCCC2)n[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.54
REN P00797 1/20 0.32
GAA P10253 1/20 0.31
TSHR P16473 2/20 0.31
ALDH1A1 P00352 2/20 0.31
CYP2D6 P10635 2/20 0.31
OPRM1 P35372 2/20 0.31
CYP3A4 P08684 2/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
CHRM2 P08172 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
ADRA1A P35348 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122180 0.88 GHSR (0.57) GHSRRENGAATSHRALDH1A1
SCHEMBL1709597 0.88 GHSR (0.53) GHSRRENGAAALDH1A1OPRK1
SCHEMBL1709555 0.88 GHSR (0.54) GHSRTSHRALDH1A1CYP3A4LMNA
SCHEMBL10122124 0.88 GHSR (0.54) GHSRRENGAATSHRALDH1A1
SCHEMBL10121891 0.88 GHSR (0.56) GHSRRENGAATSHRALDH1A1
SCHEMBL10122192 0.88 GHSR (0.57) GHSRRENGAATSHRALDH1A1
SCHEMBL1709669 0.87 GHSR (0.54) GHSRRENGAATSHRALDH1A1
SCHEMBL10122185 0.87 GHSR (0.58) GHSRGAALMNASCN1ASCN2A
SCHEMBL1709563 0.86 GHSR (0.60) GHSRGAAALDH1A1LMNACYP1A2
SCHEMBL1709696 0.85 GHSR (0.56) GHSRGAATSHRALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885REN 506/4885GAA 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.